Challenges Posed to Pathologists in the Detection of KRAS Mutations in Colorectal Cancers
作者： Jonathan Dudley , Li-Hui Tseng , Lisa Rooper , Marco Harris , Lisa Haley
DOI: 10.5858/ARPA.2013-0649-OA
关键词:
摘要: Context.— Detection of KRAS mutation is mandatory to predict response anti–epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancers. Objective.— To d...
allenpress.com
archivesofpathology.org
elsevier.com参考文章(34)
Bárbara Angulo, Elena García-García, Rebeca Martínez, Ana Suárez-Gauthier, Esther Conde, Manuel Hidalgo, Fernando López-Ríos, A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations The Journal of Molecular Diagnostics. ,vol. 12, pp. 292- 299 ,(2010) , 10.2353/JMOLDX.2010.090139
Anne Jouret-Mourin, P Demetter, Christine Sempoux, G De Hertogh, A Hoorens, E Teugels, Accurate KRAS mutation testing for EGFR-targeted therapy in colorectal cancer: emphasis on the key role and responsibility of pathologists. Acta Gastro-enterologica Belgica. ,vol. 73, pp. 497- 503 ,(2010)
Viviana Bazan, Gaspare La Rocca, Simona Corsale, Valentina Agnese, Marcella Macaluso, Manuela Migliavacca, Valter Gregorio, Sandra Cascio, Pasqua Sandra Sisto, Gaetana Di Fede, Maria Buscemi, Eugenio Fiorentino, Rita Passantino, Vincenza Morello, Rosa Maria Tomasino, Antonio Russo, Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas. Journal of Cellular Physiology. ,vol. 202, pp. 503- 509 ,(2005) , 10.1002/JCP.20150
Sarah L. Ondrejka, David F. Schaeffer, Maureen A. Jakubowski, David A. Owen, Mary P. Bronner, Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing? The American Journal of Surgical Pathology. ,vol. 35, pp. 1327- 1330 ,(2011) , 10.1097/PAS.0B013E3182253800
Hollis Viray, Kevin Li, Thomas A. Long, Patricia Vasalos, Julia A. Bridge, Lawrence J. Jennings, Kevin C. Halling, Meera Hameed, David L. Rimm, A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. Archives of Pathology & Laboratory Medicine. ,vol. 137, pp. 1545- 1549 ,(2013) , 10.5858/ARPA.2012-0561-CP
Sinchita Roy Chowdhuri, Liqiang Xi, Trinh Hoc-Tran Pham, Jeffrey Hanson, Jaime Rodriguez-Canales, Arlene Berman, Arun Rajan, Giuseppe Giaccone, Michael Emmert-Buck, Mark Raffeld, Armando C Filie, EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection. Modern Pathology. ,vol. 25, pp. 548- 555 ,(2012) , 10.1038/MODPATHOL.2011.184
Takashi Kobunai, Toshiaki Watanabe, Yoko Yamamoto, Kiyoshi Eshima, The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: A comparison between direct sequencing and real-time PCR Biochemical and Biophysical Research Communications. ,vol. 395, pp. 158- 162 ,(2010) , 10.1016/J.BBRC.2010.03.167
Thomas P. Plesec, Jennifer L. Hunt, KRAS mutation testing in colorectal cancer. Advances in Anatomic Pathology. ,vol. 16, pp. 196- 203 ,(2009) , 10.1097/PAP.0B013E3181A9D4ED
Hongdo Do, Michael Krypuy, Paul L Mitchell, Stephen B Fox, Alexander Dobrovic, High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies BMC Cancer. ,vol. 8, pp. 142- 142 ,(2008) , 10.1186/1471-2407-8-142
Kelly Oliner, Todd Juan, Sid Suggs, Michael Wolf, Ildiko Sarosi, Daniel J Freeman, Tibor Gyuris, Will Baron, Andreas Bakker, Alex Parker, Scott D Patterson, A comparability study of 5 commercial KRAS tests Diagnostic Pathology. ,vol. 5, pp. 23- 23 ,(2010) , 10.1186/1746-1596-5-23